Entia
Entia is a medical technology company that specializes in improving access to blood test.
Entia has raised €39M across 3 funding rounds from 4 investors, most recently a Series A round in Jul 2023. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKwww.entia.co ↗
Total raised
€39M
€38,718,141
Funding rounds
3
Investors
4
distinct backers
Active since
2021-10
latest 2023-07
Funding by year
EUR raised per yearEntia — funding by year — interactive chart.
Data table
| Entia — funding by year | |
|---|---|
| 2021 | €21M |
| 2023 | €18M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-07-27 | Series A | €18M | BGF,Parkwalk Advisors | View deal → |
| 2021-10-11 | Other | €10M | BGF,Parkwalk Advisors,Sussex Place Ventures | View deal → |
| 2021-10-08 | Other | €10M | BGF,Parkwalk Advisors,Sussex Place Ventures | View deal → |
Related news
- London based medical tech company raises $12m to launch virtual oncology solutionbdaily.co.uk · 2021-10
- BGF invests USD12m in Pfizer-backed virtual oncology business Entiaprivateequitywire.co.uk · 2021-10
- tech.eu
Similar companies
same sector or countryGlobal coverage: FundingData